alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Home › Research › Topics › insulin-degrading-enzyme

insulin-degrading-enzyme

2 studies tagged insulin-degrading-enzyme, dated 2003-01-01 to 2005-02-17. Bibliography: BibTeX (.bib) · RIS (.ris)

Newest in this topic

  1. Insulin, insulin-degrading enzyme and amyloid-beta peptide in Alzheimer's disease: review and hypothesis 2005-02-17
  2. Reduced hippocampal insulin-degrading enzyme in late-onset Alzheimer's disease is associated with the apolipoprotein E-epsilon4 allele 2003-01-01

Studies

2 studies carry this tag.

Date range

2003 to 2005

Top journals

  • Neurobiology of aging 1
  • The American journal of pathology 1

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. Insulin, insulin-degrading enzyme and amyloid-beta peptide in Alzheimer's disease: review and hypothesis

    ✓ Peer-reviewed alzhub usefulness score 36 out of 100. Neurobiology of aging 2005-02-17 Genetics

    Clinical and epidemiological studies have found that type 2 diabetes, and hyperinsulinaemia, increased the risk of developing Alzheimer's disease (AD) in the elderly.

  2. Reduced hippocampal insulin-degrading enzyme in late-onset Alzheimer's disease is associated with the apolipoprotein E-epsilon4 allele

    ✓ Peer-reviewed alzhub usefulness score 36 out of 100. The American journal of pathology 2003-01-01 Genetics

    Abeta is the major component of amyloid plaques characterizing Alzheimer's disease (AD).

All topic tags with their study counts